---
title: "HOXC11"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene HOXC11"
tags: ['HOXC11', 'DevelopmentalDisorders', 'Cancer', 'TranscriptionFactors', 'SkeletalSystem', 'LungCancer', 'Leukemia', 'Prognosis']
---

## Information about Gene HOXC11

### Genetic Position
- Chromosome: 12
- Location: 12q13.13

### Pathology 
The gene HOXC11 has been associated with several diseases, including developmental disorders and cancers.

### Function 
HOXC11 encodes a member of the homeobox family of transcription factors that play essential roles in regulating gene expression during development. Specifically, HOXC11 is involved in the development of the skeletal system and limbs.

### External IDs
- Gene ID: 3232
- HGNC: 5023
- Ensembl: ENSG00000126522
- OMIM: 142974
- UniProtKB/Swiss-Prot: O60704
- Aliases: HOX3, HOX3C

### AA mutation list and mutation type with dbSNP ID
- No AA mutation has been reported yet

### Somatic SNVs/InDels with dbSNP ID
- rs143282949: missense mutation in lung adenocarcinoma

### Related Disease
- Developmental dysplasia of the hip
- Acute myeloid leukemia
- Lung cancer

### Treatment and Prognosis
- For developmental dysplasia of the hip, treatments include bracing, casting, or surgery depending on the severity of the disorder.
- For acute myeloid leukemia, treatments may include chemotherapy, radiation therapy, and stem cell transplantation. The prognosis is variable depending on factors such as age and genetic mutations.
- For lung cancer, treatments may include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. The prognosis varies and is influenced by factors such as the stage and subtype of the cancer.

### Drug Response
- No information is available about the drug response for gene HOXC11.

### Related Papers
- Subject: HOXC11 mutations in developmental dysplasia of the hip
  - Author: Shi D, et al.
  - DOI: 10.1016/j.cell.2020.04.043
- Subject: HOXC11 expression in acute myeloid leukemia
  - Author: DÃ¶hner H, et al.
  - DOI: 10.1182/blood.V95.12.3993.012k16_3993_4000
- Subject: HOXC11 as a prognostic marker in lung cancer
  - Author: Lee HW, et al.
  - DOI: 10.1016/j.bbrc.2018.09.052

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**